Edwards shareholders approve 7M share increase in Long-Term Stock Program

Edwards Lifesciences Corp

Stockholders authorized 7M additional shares, raising total available to 341.5M under the amended program.
All 9 director nominees reelected; proposal received between 428M and 474M For votes each.
Advisory vote on named executive officer compensation passed with ~89% of votes cast.
Ratification of PwC as independent auditor for FY2026 approved with ~89% of votes cast.
Stock program amendment (Proposal 4) passed with 456.7M For (96% of votes cast, excluding broker non-votes).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.